Nucleai Company

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
Technology: Machine Learning
Industry: Data Processing
Headquarters: Tel Aviv, Tel Aviv, Israel
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 13500000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-07-07
Last Funding Type: Series A

Visit Website
Register and Claim Ownership